Objective: To evaluate the newborn hearing screening program in the University of Santo Tomas Hospital based on the quality indicators set by the Joint Committee on Infant Hearing (JCIH) 2019 position statement. Methods: Design: Cross-sectional study Setting: Tertiary Private Training Hospital Participants: All newborns delivered in 2019 at the University of Santo Tomas (UST) Hospital were considered for inclusion Results: The UST Hospital had 778 newborns in 2019, of which 687 (88.3%) completed newborn hearing screening by 1 month of age. There were 81 (10.4%) who failed initial hospitalbased screening and required outpatient re-screening while 11 (1.4%) of those who failed initial screening also failed subsequent rescreening. Forty-five (5.7%) newborns failed initial screening and subsequently passed re-screening. None of the eleven (0/11) patients completed comprehensive audiologic evaluation thus, patients necessitating referral for intervention were not identified. There were a total of 67 (8.6%) dropouts throughout the hearing evaluation process. Fifteen (15) infants were not screened due to unavailability of trained personnel at time of referral, four (4) infants were advised third screening while two (2) were advised observation instead of proceeding to confirmatory test. Conclusion The University of Santo Tomas Hospital newborn hearing screening program has yet to reach the quality indicators set by the Joint Committee on Infant Hearing 2019 for screening and confirmation of hearing loss. Among identified areas for improvement are the availability of trained personnel, insufficient means to ensure compliance, reluctance to pursue further testing and practices among healthcare providers.
otoacoustic emission ; diagnostics ; quality indicators

No abstract available.
Colonoscopy ; England ; Quality Indicators, Health Care

No abstract available.
Colonoscopy ; England ; Quality Indicators, Health Care

BACKGROUND/AIMS: The colonoscopic withdrawal time has been proposed as a quality indicator for colonoscopy, and this is based on the recent evidence that the Colon withdrawal time is associated with adenoma detection rate. In this study, we examined the difference of the polyp detection rates between practicing endoscopists, and we analysed certain factors that might lead to such differences, and particularly the colonoscopic withdrawal time. METHODS: We retrospectively evaluated the colonoscopic procedures that were performed by 7 second-year GI fellows at Hanyang University Guri Hospital. A total of 1,515 colonoscopies were assessed for the polyp detection rate, the insertion time, the withdrawal time, bowel preparation, the size of the detected polyps and the location of polyps. RESULTS: The median withdrawal time for the case with no polyps removed was 3.6 to 7.1 minutes. There was a strong positive correlation between the colonoscopic withdrawal times and the polyp detection rates (p<0.001). Furthermore, a longer withdrawal time resulted in discovering a higher percentage of small polyps. On comparing groups, the group of colonoscopists with a withdrawal time longer than 6 minutes had a higher rate of detecting polyps (30.7% vs 18.4%, p<0.001). CONCLUSIONS: There is wide range of polyp detection rates among practicing colonoscopists and there is strong positive correlation between the colonoscopic withdrawal times and the rate of detecting polyps. A long enough withdrawal time, perhaps 7 minutes, is needed to raise the rate of detecting polyps during colonoscopy.
Adenoma ; Colon ; Colonoscopy ; Polyps ; Quality Indicators, Health Care ; Retrospective Studies

BACKGROUND: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) are used increasingly for tacrolimus monitoring. However, there are still variability of results due to home-brew reagents, so which cannot be warrantable data. We evaluated the analytical performance and clinical usefulness of a newly introduced MassTrak LC/MS/MS Tacrolimus kit (Waters Corporation, USA). METHODS: The performance of LC-MS/MS for determination of tacrolimus concentration were analyzed using patient samples and MassTrak LC/MS/MS Tacrolimus kit including calibrators, quality controls, internal standard, column and neat solution with respect to linearity, precision, lower limit of detection, lower limit of quantitation, sample carryover and comparison according to CLSI guidelines. The LC-MS/MS using home-brew reagents were performed for comparison test. RESULTS: The LC-MS/MS using MassTrak LC/MS/MS Tacrolimus kit showed a good linearity (R2> or =0.997) and precision (CV< 8%). Assigned LLOD (0.4 ng/mL) and LLOQ (0.8 ng/mL) were validated and carryover was estimated 0.5%. The system correlated well with the LC-MS/MS using home-brew reagents (R> or =0.974). CONCLUSIONS: LC-MS/MS using MassTrak LC/MS/MS Tacrolimus kit for determination of tacrolimus concentration showed good performance for linearity, precision, LLOD, LLOQ, carryover and comparison. Introduction of MassTrak LC/MS/MS Tacrolimus kit could be warranted results by manufacturer and useful for management of quality control.
Humans ; Indicators and Reagents ; Limit of Detection ; Mass Spectrometry ; Quality Control ; Tacrolimus

Child ; China ; Humans ; Pediatrics ; Quality Indicators, Health Care ; Research

The hospital readmission rate has been widely used as an indicator of the quality of hospital care in many countries. However, the transferrability of this indicator that has been developed in a different health care system can be questioned. We reviewed what should be considered when using the risk-standardized readmission rate (RSRR) as a generic quality indicator in the Korean setting. We addressed the relationship between RSRR and the quality of hospital care, methodological aspects of RSRR, and use of RSRR for external purposes. These issues can influence the validity of the readmission rate as a generic quality indicator. Therefore RSRR should be used with care and further studies are needed to enhance the validity of the readmission rate indicator.
Delivery of Health Care ; Patient Readmission ; Quality Indicators, Health Care

This article reviews the development and administration of Shanghai IVDs (In Vitro Diagnostics) manufactures by analyzing the administration and history of the regulation of IVDs in ten years. It is to find out the problems in the administration of IVDs manufactures and products, and to make suggestions for improvements.
China ; Indicators and Reagents ; Public Sector ; organization & administration ; Quality Control

BACKGROUND: Among the results of an unexpected antibody screening test using IH-1000, ‘undeterminable’ results can be obtained. Repeated tests not only use reagents and consumables but also cause a turnaround time delay. Therefore, it is important to reduce the ‘undeterminable’ results and to determine the effects. METHODS: From January to early June, 2016, 2,872 cases/259,455 tests (1.11%) of ‘undeterminable’ were detected in the screening test. The factors considered to affect the ‘undeterminable’ were classified into four categories: ① reagent, ② consumables, ③ inspection environment & specimen, and ④ enhancing the equipment management. For data comparison, a chi-square test was conducted (95% confidence interval, 0.05 significant level). RESULTS: The incidence of ‘undeterminable’ cases decreased from 1.11% before management to 0.66% (P < 0.001) after Pool Cells management. The consumption of ‘LISS/Coombs Card’ decreased from 1.07% before management to 0.51% (P < 0.001) after management. By maintaining a clean inspection environment and strengthening sample management, the rate decreased from 1.11% before management to 0.66% (P < 0.001) after management. On the other hand, there was no difference in the incidence of ‘undeterminable’ between before and after IH-1000 management reinforcement. CONCLUSION: Among the factors predicted to affect the decrease in the incidence of ‘undeterminable’, the management of Pool Cells and keeping the inspection environment clean as well as improving sample management contributed the most to the reduced ‘undeterminable’. Improvements in the management of consumables, and removing dust from the inside of the equipment, had a positive impact. A continuous quality improvement theme has been adopted and it is helpful for managing and improving the predicted factors.
Agglutination* ; Dust ; Hand ; Incidence ; Indicators and Reagents ; Mass Screening* ; Quality Improvement

Assessment of mental health service refers to the process of using the indicator system and methods to reflect the quality or performance of mental health. Mental health evaluation can effectively promote the development of mental health system and service quality. Scientific and comprehensive indicator system is key to assessment. After long-term practice and exploration, there have been many successful assessment schemes in foreign countries, which may be used in establishing the assessment system and screening indicators in China.
China ; Health Status Indicators ; Humans ; Mental Disorders ; rehabilitation ; Mental Health Services ; standards ; Quality Indicators, Health Care ; Surveys and Questionnaires